RATIONALE: The type I subclass of coronins, a family of actin-binding proteins, regulates various actin-dependent cellular processes, including migration. However, the existence and role of coronins in vascular smooth muscle cell (VSMC) migration has yet to be determined. OBJECTIVE: The goal of the present study was to define the mechanism by which coronins regulate platelet-derived growth factor (PDGF)-induced VSMC migration. METHODS AND RESULTS: Coronin 1B (Coro1B) and 1C (Coro1C) were both found to be expressed in VSMCs at the mRNA and protein levels. Downregulation of Coro1B by siRNA increases PDGF-induced migration, while downregulation of Coro1C has no effect. We confirmed through kymograph analysis that the Coro1B-downregulation-mediated increase in migration is directly linked to increased lamellipodial protraction rate and protrusion distance in VSMC. In other cell types, coronins exert their effects on lamellipodia dynamics by an inhibitory interaction with the ARP2/3 complex, which is disrupted by the phosphorylation of Coro1B. We found that PDGF induces phosphorylation of Coro1B on serine-2 via PKCε, leading to a decrease in the interaction of Coro1B with the ARP2/3 complex. VSMCs transfected with a phosphodeficient S2A Coro1B mutant showed decreased migration in response to PDGF, suggesting that the phosphorylation of Coro1B is required for the promotion of migration by PDGF. In both the rat and mouse, Coro1B phosphorylation was increased in response to vessel injury in vivo. CONCLUSIONS: Our data suggest that phosphorylation of Coro1B and the subsequent reduced interaction with ARP2/3 complex participate in PDGF-induced VSMC migration, an important step in vascular lesion formation.
RATIONALE: The type I subclass of coronins, a family of actin-binding proteins, regulates various actin-dependent cellular processes, including migration. However, the existence and role of coronins in vascular smooth muscle cell (VSMC) migration has yet to be determined. OBJECTIVE: The goal of the present study was to define the mechanism by which coronins regulate platelet-derived growth factor (PDGF)-induced VSMC migration. METHODS AND RESULTS:Coronin 1B (Coro1B) and 1C (Coro1C) were both found to be expressed in VSMCs at the mRNA and protein levels. Downregulation of Coro1B by siRNA increases PDGF-induced migration, while downregulation of Coro1C has no effect. We confirmed through kymograph analysis that the Coro1B-downregulation-mediated increase in migration is directly linked to increased lamellipodial protraction rate and protrusion distance in VSMC. In other cell types, coronins exert their effects on lamellipodia dynamics by an inhibitory interaction with the ARP2/3 complex, which is disrupted by the phosphorylation of Coro1B. We found that PDGF induces phosphorylation of Coro1B on serine-2 via PKCε, leading to a decrease in the interaction of Coro1B with the ARP2/3 complex. VSMCs transfected with a phosphodeficient S2A Coro1B mutant showed decreased migration in response to PDGF, suggesting that the phosphorylation of Coro1B is required for the promotion of migration by PDGF. In both the rat and mouse, Coro1B phosphorylation was increased in response to vessel injury in vivo. CONCLUSIONS: Our data suggest that phosphorylation of Coro1B and the subsequent reduced interaction with ARP2/3 complex participate in PDGF-induced VSMC migration, an important step in vascular lesion formation.
Authors: David S Weber; Yoshihiro Taniyama; Petra Rocic; Puvi N Seshiah; Melissa A Dechert; William T Gerthoffer; Kathy K Griendling Journal: Circ Res Date: 2004-04-01 Impact factor: 17.367
Authors: Craig C Carson; Stergios J Moschos; Sharon N Edmiston; David B Darr; Nana Nikolaishvili-Feinberg; Pamela A Groben; Xin Zhou; Pei Fen Kuan; Shaily Pandey; Keefe T Chan; Jamie L Jordan; Honglin Hao; Jill S Frank; Dennis A Hopkinson; David C Gibbs; Virginia D Alldredge; Eloise Parrish; Sara C Hanna; Paula Berkowitz; David S Rubenstein; C Ryan Miller; James E Bear; David W Ollila; Norman E Sharpless; Kathleen Conway; Nancy E Thomas Journal: Clin Cancer Res Date: 2015-05-01 Impact factor: 12.531
Authors: Elyse Di Marco; Stephen P Gray; Kit Kennedy; Cedric Szyndralewiez; Alicia N Lyle; Bernard Lassègue; Kathy K Griendling; Mark E Cooper; Harald H H W Schmidt; Karin A M Jandeleit-Dahm Journal: Free Radic Biol Med Date: 2016-07-19 Impact factor: 7.376
Authors: Raphael H Rastetter; Margit Blömacher; Uta Drebber; Marija Marko; Juliane Behrens; Roxana Solga; Sarah Hojeili; Kurchi Bhattacharya; Claudia M Wunderlich; F Thomas Wunderlich; Margarete Odenthal; Anja Ziemann; Ludwig Eichinger; Christoph S Clemen Journal: BMC Cancer Date: 2015-09-15 Impact factor: 4.430
Authors: Peter V Usatyuk; Michael Burns; Vijay Mohan; Srikanth Pendyala; Donghong He; David L Ebenezer; Anantha Harijith; Panfeng Fu; Long Shuang Huang; James E Bear; Joe G N Garcia; Viswanathan Natarajan Journal: PLoS One Date: 2013-05-08 Impact factor: 3.240
Authors: Elke H Heiss; Daniel Schachner; Maddalena Donati; Christoph S Grojer; Verena M Dirsch Journal: Vascul Pharmacol Date: 2016-05-14 Impact factor: 5.773